Iron regulatory protein 1 as a sensor of reactive oxygen species

BioFactors

Volumn 24, Issue 1-4, 2005, Pages 171-181

  Mueller, Sebastian ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; FERRITIN; HYDROGEN PEROXIDE; HYPOCHLORITE; IRON REGULATORY PROTEIN 1; IRON REGULATORY PROTEIN 2; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TRANSFERRIN RECEPTOR;

ANEMIA; ARTICLE; BIOACCUMULATION; BIOSENSOR; CHRONIC DISEASE; CYTOTOXICITY; HOMEOSTASIS; HUMAN; INFLAMMATION; IRON METABOLISM; MOLECULAR DYNAMICS; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN RNA BINDING; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EUKARYOTA;

EID: 28644443925     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520240121     Document Type: Article

References (91)

1. 2 gradients across biomembranes, FEBS Lett. 475 (2000), 121-126.
2. B.M. Babior, Oxygen-dependent microbial killing by phagocytes, N. Engl. J. Med. 298 (1978), 659-668.
3. M. Baggiolini and M. Theian, The phagocytes and the respiratory burst, in: H. Sies, ed., Oxidative Stress: Oxidants and Antioxidants, Harcourt Brace Jovanovich, London, 1991.
4. H. Beinert, R.H. Holm and E. Munck, Iron-sulfur clusters: Nature's modular, multipurpose structures, Science 277 (1997), 653-659.
5. T. Bilinski, Oxygen toxicity and microbial evolution, BioSystems 24 (1991), 305-312.
6. H.L. Bonkovsky, R.W. Lambrecht and Y. Shan, Iron as a co-morbid factor in nonhemochromatotic liver disease. Alcohol 30 (2003), 137-144.
7. C. Bouton, M. Raveau and J.C. Drapier, Modulation of iron regulatory protein functions. Further insights into the role of nitrogen- and oxygen-derived reactive species, J. Biol. Chem. 271 (1996), 2300-2306.
8. X. Brazzolotto, M. Andriollo, P. Guiraud, A. Favier and J.M. Moulis, Interactions between doxorubicin and the human iron regulatory system, Biochim. Biophys. Acta 1593 (2003), 209-218.
9. X. Brazzolotto, J. Gaillard, K. Pantopoulos, M.W. Hentze and J.M. Moulis, Human cytoplasmic aconitase (Iron regulatory protein 1) is converted into its [3Fe-4S] form by hydrogen peroxide in vitro but is not activated for iron-responsive element binding, J. Biol. Chem. 274 (1999), 21625-21630.
10. W. Breuer, S. Epsztejn and Z.I. Cabantchik, Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron(II), J. Biol. Chem. 270 (1995), 24209-24215.
11. E. Cadenas. Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism, Biochem. Pharmacol. 49 (1995), 127-140.
12. G. Cairo, E. Castrusini, G. Minotti and A. Bernelli-Zazzera, Superoxide and hydrogen peroxide-dependent inhibition of iron regulatory protein activity: A protective stratagem against oxidative injury, Faseb J. 10 (1996), 1326-1335.
13. G. Cairo and A. Pietrangelo, Iron regulatory proteins in pathobiology, Biochem J 352(2) (2000), 241-250.
14. G. Cairo and A. Pietrangelo, Nitric-oxide-mediated activation of iron-regulatory protein controls hepatic iron metabolism during acute inflammation, Eur. J. Biochem, 232 (1995), 358-363.
15. G. Cairo, L. Tacchini, S. Recalcati, B. Azzimonti, G. Minotti and A. Bernelli-Zazzera, Effect of reactive oxygen species on iron regulatory protein activity, Ann. N.Y. Acad. Sci. 851 (1998), 179-186.
16. 2 on the expression and function of iron-responsive element-containing mRNAs in B6 fibroblasts. J. Biol. Chem. 22 (2001), 22.
17. A. Campanella, S. Levi, G. Cairo, G. Biasiotto and P. Arosio, Blotting analysis of native IRP1: a novel approach to distinguish the different forms of IRP1 in cells and tissues, Biochemistry 43 (2004), 195-204.
18. G.E. Cartwright, M.A. Lauritsen, P.J. Jones, I.M. Merrill and M.M. Wintrobe, The anemia of infection. I. Hypoferremia, hypercupremia, and alterations in porphyrin metabolism in patients, J. Clin. Invest. 25 (1946), 65-80.
19. L.A. Castro, R.L. Robalinho, A. Cayota, R. Meneghini and R. Radi, Nitric oxide and peroxynitrite-dependent aconitase inactivation and iron-regulatory protein-1 activation in mammalian fibroblasts, Arch. Biochem. Biophys. 359 (1998), 215-224.
20. R.S. Eisenstein, Iron regulatory proteins and the molecular control of mammalian iron metabolism, Annu. Rev. Nutr. 20 (2000), 627-662.
21. J.N. Feder, A. Gnirke, W. Thomas, Z. Tsuchihashi, D.A. Ruddy, A. Basava, F. Dormishian, R. Domingo Jr, M.C. Ellis, A. Fullan, L.M. Hinton, N.L. Jones, B.E. Kimmel, G.S. Kronmal, P. Lauer, V.K. Lee, D.B. Loeb, F.A. Mapa, E. McClelland, N.C. Meyer, G.A. Mintier, N. Moeller, T. Moore, E. Morikang and R.K. Wolff et al., A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis, Nat. Genet. 13 (1996), 399-408.
22. B.J. Ferguson, B.S. Skikne, K.M. Simpson, R.D. Baynes and J.D. Cook, Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia, J. Lab. Clin. Med. 119 (1992), 385-390.
23. C. Fillebeen, D. Chahine, A. Caltagirone, P. Segal and K. Pantopoulos, A phosphomimetic mutation at Ser-138 renders iron regulatory protein 1 sensitive to iron-dependent degradation, Mol. Cell. Biol. 23 (2003), 6973-6981.
24. J.J.R. Frausto da Silva and R.J.P. Williams, The Biological Chemistry of the Elements: The Inorganic Chemistry of Life, Clarendon, Oxford, 1991.
25. T. Ganz, Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation, Blood 102 (2003), 783-788.
26. N.H. Gehring, M.W. Hentze and K. Pantopoulos, Inactivation of both RNA binding and aconitase activities of iron regulatory protein-1 by quinone-induced oxidative stress, J. Biol. Chem. 274 (1999), 6219-6225.
27. B. Guo, J.D. Phillips, Y. Yu and E.A. Leibold, Iron regulates the intracellular degradation of iron regulatory protein 2 by the proteasome, J. Biol. Chem. 270 (1995), 21645-21651.
28. D.J. Haile, T.A. Rouault, J.B. Harford, M.C. Kennedy, G.A. Blondin, H. Beinert and R.D. Klausner, Cellular regulation of the iron-responsive element binding protein: Disassembly of the cubane iron-sulfur cluster results in high-affinity RNA binding, Proc. Natl. Acad. Sci. USA 89 (1992), 11735-11739.
29. B. Halliwell and J.M. Gutteridge, Free Radicals in Biology and Medicine, Clarendon Press, Oxford, 1999.
30. B. Halliwell and J.M.C. Gutteridge, Role of free radicals and catalytic metal ions in human disease: An overview, Methods Enzymol. 186 (1990), 1-85.
31. E.S. Hanson, L.M. Foot and E.A. Leibold, Hypoxia post-translationally activates iron-regulatory protein 2, J. Biol. Chem. 274 (1999), 5047-5052.
32. E.S. Hanson and E.A. Leibold, Regulation of iron regulatory protein 1 during hypoxia and hypoxia/reoxygenation, J. Biol. Chem. 273 (1998), 7588-7593.
33. S. Haque, B. Chandra, M.A. Gerber and A.S. Lok, Iron overload in patients with chronic hepatitis C: A clinicopathologic study, Hum. Pathol. 27 (1996), 1277-1281.
34. A. Hausladen and I. Fridovich, Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not, J. Biol. Chem. 269 (1994), 29405-29408.
35. M.W. Hentze and L.C. Kühn, Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide and oxidative stress, Proc. Natl. Acad. Sci. USA 93 (1996), 8175-8182.
36. M.W. Hentze, M.U. Muckenthaler and N.C. Andrews, Balancing acts: Molecular control of mammalian iron metabolism, Cell 117 (2004), 285-297.
37. M. Hirayama, Y. Kohgo, H. Kondo, N. Shintani, K. Fujikawa, K. Sasaki, J. Kato and Y. Niitsu, Regulation of iron metabolism in HepG2 cells: A possible role for cytokines in the hepatic deposition of iron, Hepatology 18 (1993), 874-880.
38. K. Iwai, R.D. Klausner and T.A. Rouault, Requirements for iron-regulated degradation of the RNA binding protein, iron regulatory protein 2, EMBO J. 14 (1995), 5350-5357.
39. E. Joosten, R. Van Loon, J. Billen, N. Blanckaert, R. Fabri and W. Pelemans, Serum transferrin receptor in the evaluation of the iron status in elderly hospitalized patients with anemia, Am. J. Hematol. 69 (2002), 1-6.
40. L. Kazemi-Shirazi, C. Datz, T. Maier-Dobersberger, K. Kaserer, F. Hackl, C. Polli, P.E. Steindl, E. Penner and P. Ferenci, The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C, Gastroenterology 116 (1999), 127-134.
41. M.C. Kennedy, W.E. Antholine and H. Beinert, An EPR investigation of the products of the reaction of cytosolic and mitochondrial aconitases with nitric oxide, J. Biol. Chem. 272 (1997), 20340-20347.
42. S. Kim and P. Ponka, Nitrogen monoxide-mediated control of ferritin synthesis: Implications for macrophage iron homeostasis, Proc. Natl. Acad. Sci. USA 99 (2002), 12214-12219.
43. S.J. Klebanoff, Inflammation: Basic Principles and Clinical Correlates, in: R. Snyderman, ed., Raven Press, New York, 1988, pp. 391-444.
44. S.J. Klebanoff, Myeloperoxidase: Occurrence and biological function, in: M.B. Grisham, ed., Peroxidases in Chemistry and Biology, CRC Press, Boca Raton, 1991, pp. 1-35.
45. S. Kotamraju, C.R. Chitambar, S.V. Kalivendi, J. Joseph and B. Kalyanaraman, Transferrin receptor-dependent iron uptake is responsible for doxorubicin-mediated apoptosis in endothelial cells: Role of oxidant-induced iron signaling in apoptosis, J. Biol. Chem. 277 (2002), 17179-17187.
46. M.D. Knutson, M. Oukka, L.M. Koss, F. Aydemir and M. Wessling-Resnick, Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin, Proc. Natl. Acad. Sci. USA (2005).
47. T. LaVaute, S. Smith, S. Cooperman, K. Iwai, W. Land, E. Meyron-Holtz, S.K. Drake, G. Miller, M. Abu-Asab, M. Tsokos, R. Switzer 3rd, A. Grinberg, P. Love, N. Tresser and T.A. Rouault, Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice, Nat. Genet. 27 (2001), 209-214.
48. N. Makino, Y. Mochizuki, S. Bannai and Y. Sugita, Kinetic studies on the removal of extracellular hydrogen peroxide by cultured fibroblasts, J. Biol. Chem. 269 (1994), 1020-1025.
49. E.A. Martins, R.L. Robalinho and R. Meneghini, Oxidative stress induces activation of a cytosolic protein responsible for control of iron uptake, Arch. Biochem. Biophys. 316 (1995), 128-134.
50. J.C. Mathai and V. Sitaramam, Stretch sensitivity of transmembrane mobility of hydrogen peroxide through voids in the bilayer. Role of cardiolipin, J. Biol. Chem. 269 (1994), 17784-17793.
51. E.G. Meyron-Holtz, M.C. Ghosh, K. Iwai, T. LaVaute, X. Brazzolotto, U.V. Berger, W. Land, H. Ollivierre-Wilson, A. Grinberg, P. Love and T.A. Rouault, Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis, EMBO J. 23 (2004), 386-395.
52. E.G. Meyron-Holtz, M.C. Ghosh and T.A. Rouault, Mammalian tissue oxygen levels modulate iron-regulatory protein activities in vivo, Science 306 (2004), 2087-2090.
53. G. Minotti, S. Recalcati, A. Mordente, G. Liberi, A.M. Calafiore, C. Mancuso, P. Preziosi and G. Cairo, The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein-1 in cytosolic fractions from human myocardium [published erratum appears in FASEB J 1998 Jun;12(9):732], Faseb J 12 (1998), 541-552.
54. G. Minotti, R. Ronchi, E. Salvatorelli, P. Menna and G. Cairo, Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: Evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy, Cancer Res 61 (2001), 8422-8428.
55. F. Missirlis, J. Hu, K. Kirby, A.J. Hilliker, T.A. Rouault and J.P. Phillips, Compartment-specific protection of iron-sulfur proteins by superoxide dismutase, J. Biol. Chem. 278 (2003), 47365-47369.
56. S. Mueller, Wasserstoffperoxid als potentielles interzelluläres Signalmolekül am Beispiel der hepatischen Eisenregulation, Habilitation, University of Heidelberg, 2003.
57. 2 concentration in stimulated human neutrophils, J. Biolumin. Chemilumin. 10 (1995), 229-237.
58. E.W. Mullner and L.C. Kühn, A stem-loop in the 3′ untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm, Cell 53 (1988), 815-825.
59. S. Mueller and K. Pantopoulos, Activation of iron regulatory protein-1 (IRP1) by oxidative stress, Methods Enzymol. 348 (2002), 324-337.
60. S. Mueller, K. Pantopoulos, C.A. Hübner, W. Stremmel and M.W. Hentze, IRP1 activation by extracellular oxidative stress in the perfused rat liver, J. Biol. Chem. 276 (2001), 23192-23196.
61. S. Mueller, H.D. Riedel and W. Stremmel, Determination of catalase activity at physiological hydrogen peroxide concentrations, Anal. Biochem. 245 (1997), 55-60.
62. S. Mütze, U. Hebling, W. Stremmel, J. Wang, J. Arnhold, K. Pantopoulos and S. Mueller, Myeloperoxidase-derived hypochlorous acid antagonizes the oxidative stress-mediated activation of iron regulatory protein 1, J. Biol. Chem. 278 (2003), 40542-40549.
63. J. Narahari, R. Ma, M. Wang and W.E. Walden, The aconitase function of iron regulatory protein 1. Genetic studies in yeast implicate its role in iron-mediated redox regulation, J. Biol. Chem. 275 (2000), 16227-16234.
64. E. Nemeth, M.S. Tuttle, J. Powelson, M.B. Vaughn, A. Donovan, D.M. Ward, T. Ganz and J. Kaplan, Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization, Science 306 (2004), 2090-2093.
65. P. Nicholls, Activity of catalase in the red cell, Biochim. Biophys. Acta 99 (1965), 286-297.
66. K. Pantopoulos, Iron metabolism and the IRE/IRP regulatory system: An update, Ann. N. Y. Acad. Sci. 1012 (2004), 1-13.
67. K. Pantopoulos and M.W. Hentze. Activation of iron regulatory protein-1 by oxidative stress in vitro, Proc. Natl. Acad. Sci. USA 95 (1998), 10559-10563.
68. K. Pantopoulos and M.W. Hentze, Nitric oxide signaling to iron-regulatory protein: Direct control of ferritin mRNA translation and transferrin receptor mRNA stability in transfected fibroblasts, Proc. Natl. Acad. Sci. USA 92 (1995), 1267-1271.
69. K. Pantopoulos and M.W. Hentze, Rapid responses to oxidative stress mediated by iron regulatory protein, EMBO J. 14 (1995), 2917-2924.
70. K. Pantopoulos, S. Mueller, A. Atzberger, W. Ansorge, W. Stremmel and M.W. Hentze, Differences in the regulation of IRP-1 (iron regulatory protein-1) by extra- and intracelullar oxidative stress, J. Biol. Chem. 272 (1997), 9802-9808.
71. 2) control mammalian iron metabolism by different pathways, Mol. Cell. Biol. 16 (1996), 3781-3788.
72. A. Piperno, A. Vergani, I. Malosio, L. Parma, L. Fossati, A. Ricci, G. Bovo, G. Boari and G. Mancia, Hepatic iron overload in patients with chronic viral hepatitis: Role of HFE gene mutations, Hepatology 28 (1998), 1105-1109.
73. J.S. Pitula, K.M. Deck, S.L. Clarke, S.A. Anderson, A. Vasanthakumar and R.S. Eisenstein, Selective inhibition of the citrate-to-isocitrate reaction of cytosolic aconitase by phosphomimetic mutation of serine-711, Proc. Natl. Acad. Sci. USA 101 (2004), 10907-10912.
74. P. Ponka, Cell biology of heme, Am. J. Med. Sci. 318 (1999), 241-256.
75. J.M. Pullar, C.C. Winterbourn and M.C. Vissers, Loss of GSH and thiol enzymes in endothelial cells exposed to sublethal concentrations of hypochlorous acid, Am. J. Physiol. 277 (1999), H1505-H1512.
76. M.R. Quastel and J.F. Ross, The effect of acute inflammation on the utilization and distribution of trasnferrin-bound and erythrocyte radioiron, Blood 28 (1966), 738-757.
77. O. Riggio, F. Montagnese, P. Fiore, S. Folino, S. Giambartolomei, C. Gandin, M. Merli, I. Quinti, N. Violante, S. Caroli, O. Senofonte and L. Capocaccia, Iron overload in patients with chronic viral hepatitis: How common is it? Am. J. Gastroenterol. 92 (1997), 1298-1301.
78. 2) induces transferrin receptor mediated iron uptake in vitro and in vivo, (submitted for publication), 2005.
79. S. Rothenberger, E.W. Mullner and L.C. Kuhn, The mRNA-binding protein which controls ferritin and transferrin receptor expression is conserved during evolution, Nucleic Acids Res. 18 (1990), 1175-1179.
80. T. Rouault and R. Klausner, Regulation of iron metabolism in eukaryotes, Curr. Top. Cell. Regul. 35 (1997), 1-19.
81. K.-H. Schäfer, Über den Einfluß von Infektionen und ähnlichen Vorgängen auf den Eisenstoffwechsel, Zeitschrift für die gesamte experimentelle Medizin 110 (1942), 678-696.
82. R.R. Starzynski, P. Lipinski, J.C. Drapier, A. Diet, E. Smuda, T. Bartlomiejczyk, M.A. Gralak and M. Kruszewski, Down-regulation of iron regulatory protein 1 activities and expression in superoxide dismutase 1 knockout mice is not associated with alterations in iron metabolism, J. Biol. Chem. (2004).
83. 2 and not superoxide determines the functionality of iron regulatory potein 1 and its downstream target transferrin receptor, Free Radic. Res. (in press), 2005.
84. 2-mediated expression of transferrin receptor 1, Free Radic. Res. (in press), 2004.
85. P. Ubezio and F. Civoli, Flow cytometric detection of hydrogen peroxide production induced by doxorubicin in cancer cells, Free Radical Biology and Medicine 16 (1994), 509-516.
86. R.L. Upton, Y. Chen, S. Mumby, J.M. Gutteridge, P.B. Anning, A.G. Nicholson, T.W. Evans and G.J. Quinlan, Variable tissue expression of transferrin receptors: Relevance to acute respiratory distress syndrome, Eur. Respir. J. 22 (2003), 335-341.
87. W. Volland, Untersuchungen über den intermediären Eisenstoffwechsel nach wiederholter Injektion artfremden Serums, Klin. Wochenschr. 19 (1940), 1242.
88. S. Wang, S. Kotamraju, E. Konorev, S. Kalivendi, J. Joseph and B. Kalyanaraman, Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: The role of hydrogen peroxide, Biochem J 367 (2002), 729-740.
89. J. Wang and K. Pantopoulos, Conditional derepression of ferritin synthesis in cells expressing a constitutive IRP1 mutant, Mol. Cell. Biol. 22 (2002), 4638-4651.
90. G. Weiss, Iron and anemia of chronic disease, Kidney Int. Suppl. 69 (1999), S12-S17.
91. R. Wisnicka, A. Krzepilko, J. Wawryn, Z. Krawiec and T. Bilinski, Protective role of superoxide dismutase in iron toxicity in yeast, Biochem. Mol. Biol. Int. 44 (1998), 635-641.